ArticleKidney medicine2024

Allopurinol, Febuxostat, and Nonuse of Xanthine Oxidoreductase Inhibitor Treatment in Patients Receiving Hemodialysis: A Longitudinal Analysis.

Takeo Ishii et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.